ストックスクリーナーアプリを入手
0.37
14.21%
-0.0613
アフターアワーズ：
.35
-0.02
-5.41%
Enzo Biochem Inc (ENZ) 最新ニュース
Enzo Biochem to Delist from NYSE, Move to OTCQX - TipRanks
Enzo Biochem stock hits 52-week low at $0.33 amid market challenges - Investing.com Australia
StockNews.com Begins Coverage on Enzo Biochem (NYSE:ENZ) - Defense World
Enzo Biochem to delist from NYSE, move to OTCQX market By Investing.com - Investing.com South Africa
Enzo Biochem to voluntarily delist from NYSE and transfer trading of shares to OTCQX; shares fall - MSN
Enzo Biochem to delist from NYSE, move to OTCQX market - Investing.com India
Enzo Biochem (ENZ) to Voluntarily Delist from NYSE, Move to OTCQ - GuruFocus
Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX - The Manila Times
Enzo Biochem Announces Notification to New York Stock - GlobeNewswire
Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily - Bluefield Daily Telegraph
NYSE Delisting Alert: Enzo Biochem Moving to OTCQXWhat Shareholders Must Know - Stock Titan
Here’s Why Enzo Biochem (ENZ) Declined in Q4 - Yahoo Finance
ENZ Stock Down Following Q2 Earnings, Revenues Decline Y/Y - Nasdaq
Enzo Biochem Inc (ENZ) Reports Q2 Fiscal 2025 Revenue of $7.3 Mi - GuruFocus.com
Enzo Biochem: Fiscal Q2 Earnings Snapshot - The Pioneer
Enzo Biochem Reports Decline in Quarterly Revenues - TipRanks
Enzo Biochem Inc. ($0.01 Par Value) (ENZ) reports earnings - Quartz
Enzo Biochem Stages Comeback: Q2 Shows 18% Growth, Key Segment Returns to Profit - StockTitan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Enzo Biochem: Fiscal Q2 Earnings Snapshot -March 17, 2025 at 04:30 pm EDT - Marketscreener.com
ENZO BIOCHEM INC SEC 10-Q Report - TradingView
Enzo Biochem Reports Second Quarter Fiscal Year 2025 Results - GlobeNewswire
Protein Stability Analysis Market Future Business - openPR
Enzo Biochem (NYSE:ENZ) Coverage Initiated by Analysts at StockNews.com - Defense World
Enzo Biochem, Inc. to Host Earnings Call - ACCESS Newswire
Enzo Biochem (NYSE:ENZ) Earns Hold Rating from Analysts at StockNews.com - Defense World
Protein Stability Analysis Market Generated Opportunities, - openPR
Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com - Defense World
Enzo Biochem, Inc.'s (NYSE:ENZ) 28% Share Price Plunge Could Signal Some Risk - Simply Wall St
Enzo Biochem stock hits 52-week low at $0.51 amid challenges - MSN
ENZ Stock Earnings: Enzo Biochem Reported Results for Q3 2024 - MSN
Neuroscience Antibodies and Assays Market to Grow by USD 2.20 Billion from 2024-2028, Rising Neurological Disorders Boost Growth, Report on How AI is Redefining Market LandscapeTechnavio - The Malaysian Reserve
NYAG’s Enforcement of Mandated Cybersecurity Safeguards Sends Expensive Shock Waves through Varying Industries - Law.com
StockNews.com Initiates Coverage on Enzo Biochem (NYSE:ENZ) - Defense World
Enzo Biochem stock hits 52-week low at $0.63 amid market challenges - Investing.com Canada
Enzo Biochem stock hits 52-week low at $0.63 amid market challenges By Investing.com - Investing.com South Africa
1.12%
1.76%
大文字化:
|
ボリューム (24 時間):